Latest News in the pharma Industry

Market News

UAE pharmaceutical market set to hit $5.7 billion by 2020 as medical tourism grows

UAE pharmaceutical market set to hit $5.7 billion by 2020 as medical tourism grows

10 Oct 2016

The UAE is quickly gaining popularity as a medical tourism destination due to its low costs, English-speaking medical staff, and virtually non-existent queues for treatment.

Read more 
Mylan agrees to settlement on Medicaid Rebate Classification for EpiPen Auto-Injector

Mylan agrees to settlement on Medicaid Rebate Classification for EpiPen Auto-Injector

10 Oct 2016

The terms of the settlement do not provide for any finding of wrongdoing on the part of Mylan Inc. or any of its affiliated entities or personnel.

Read more 
Enterprise Therapeutics secures £4M funding to advance therapies for patients with respiratory disease

Enterprise Therapeutics secures £4M funding to advance therapies for patients with respiratory disease

10 Nov 2016

Funding will allow the company to advance its research projects and move closer towards its goal of evaluating the efficacy of muco-regulatory drugs in patients.

Read more 
The first nutritional supplement against TB launches in Asia and Africa

The first nutritional supplement against TB launches in Asia and Africa

9 Oct 2016

Nyaditum resae targets to reduce the risk of developing the disease in people who carry the tuberculosis bacteria and those at risk of infection.

Read more 
Orchard Therapeutics opens US operations in Foster City, California

Orchard Therapeutics opens US operations in Foster City, California

7 Oct 2016

Will provide the central technical base for laboratory operations associated with the development and validation of manufacturing processes and analytical methods for the company’s products.

Read more 
BARDA awards $37.6 million contract to Sanofi to supply Leukine for potential public health emergency

BARDA awards $37.6 million contract to Sanofi to supply Leukine for potential public health emergency

7 Oct 2016

Sanofi Genzyme expects to submit a supplemental Biologics License Application to the FDA next year.

Read more 
Colorcon strengthens its global production capacity with a new Latin American manufacturing facility

Colorcon strengthens its global production capacity with a new Latin American manufacturing facility

7 Oct 2016

Company to start manufacturing in Brazil.

Read more 
Pall Life Sciences wins BPI 2016 Best Downstream Application Award

Pall Life Sciences wins BPI 2016 Best Downstream Application Award

6 Oct 2016

Cadence Acoustic Separator system is a novel single-use solution for the clarification of cell culture bioprocess fluids.

Read more 
Gastrointestinal drugs market to hit $48.4 billion by 2022 as biologic products revolutionize the treatment space

Gastrointestinal drugs market to hit $48.4 billion by 2022 as biologic products revolutionize the treatment space

6 Oct 2016

Although the market has recently been hit by the patent expirations of a number of the leading gastrointestinal products, the approval of new drugs, as well as rising prevalence, are expected to drive considerable growth. says GBI Research.

Read more 
Lilly subsidiary to acquire Boehringer Ingelheim Vetmedica's US feline, canine and rabies vaccines portfolio

Lilly subsidiary to acquire Boehringer Ingelheim Vetmedica's US feline, canine and rabies vaccines portfolio

6 Oct 2016

Eight new product lines and a fully integrated manufacturing and R&D site to transfer to Elanco, adding to its growing companion animal business.

Read more 
Intas Pharmaceuticals acquires Actavis UK & Ireland generics businesses from Teva

Intas Pharmaceuticals acquires Actavis UK & Ireland generics businesses from Teva

6 Oct 2016

Transaction is part of the European Commission’s anti-trust divestiture requirements arising from Teva’s acquisition of Allergan’s generics business.

Read more 
Patent trial and appeal board upholds the validity of Lialda patent

Patent trial and appeal board upholds the validity of Lialda patent

6 Oct 2016

Shire pleased with the decision and will continue to vigorously defend its patents.

Read more